M&A Deal Summary |
|
---|---|
Date | 2016-12-14 |
Target | Hologic - NAT |
Sector | Test/Measurement Equipment |
Buyer(s) | Grifols |
Sellers(s) | Hologic |
Deal Type | Divestiture |
Deal Value | 1.9B USD |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1909 |
Sector | Healthcare Services |
Employees | 23,000 |
Revenue | 6.6B EUR (2023) |
Grifols is a global healthcare company and biopharmaceutical manufacturer. Grifols was founded in 1909 and is based in Barcelona, Spain.
DEAL STATS | # |
---|---|
Overall | 4 of 8 |
Sector (Test/Measurement Equipment) | 1 of 1 |
Type (Divestiture) | 2 of 3 |
Country (United States) | 3 of 6 |
Year (2016) | 1 of 1 |
Size (of disclosed) | 1 of 3 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2015-03-04 |
Alkahest
San Carlos, California, United States Alkahest is focused on developing therapies derived from blood to treat neurological diseases, with an emphasis on the age-related cognitive decline key medical challenges. The company’s research has demonstrated that factors in the blood plasma of young mice are able to reverse brain deficits in normal aging and Alzheimer’s disease models in mice. Alkahest was formed in 2014 and is based in San Carlos, California. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2017-07-05 |
GigaGen
South San Francisco, California, United States GigaGen is a biotechnology company specialized in the early discovery and development of recombinant biotherapeutic medicines. GigaGen’s research focuses on discovering new biological treatments based on antibodies derived from millions of immune system cells obtained from donors. GigaGen currently spearheads several in-house research projects, including the development of the world’s first recombinant polyclonal immunoglobulin and a portfolio of immuno-oncological therapies. |
Buy | - |
Category | Company |
---|---|
Founded | 1985 |
Sector | Medical Products |
Employees | 6,944 |
Revenue | 4.0B USD (2023) |
Hologic is a developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products, with an emphasis on serving the healthcare needs of women throughout the world. Hologic was formed in 1985 and is based in Marlborough, Massachusetts.
DEAL STATS | # |
---|---|
Overall | 3 of 4 |
Sector (Test/Measurement Equipment) | 1 of 1 |
Type (Divestiture) | 3 of 4 |
Country (United States) | 3 of 4 |
Year (2016) | 1 of 1 |
Size (of disclosed) | 1 of 3 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2013-01-03 |
Hologic - LIFECODES business
United States Hologic - LIFECODES business includes transplantation diagnostics. LIFECODES sells molecular and antibody-based assays in the markets of transplant diagnostics, specialty coagulation and transfusion medicine. |
Sell | $85M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2017-02-14 |
Cynosure
Westford, Massachusetts, United States Cynosure is a developer and marketer of aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and pigmented lesions, rejuvenate the skin, liquefy and remove unwanted fat through laser lipolysis and temporarily reduce the appearance of cellulite. Cynosure was founded in 1991 and is based in Westford, Massachusetts. |
Buy | $1.7B |